Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: Report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors

American Journal of Surgical Pathology

Volumn 28, Issue 8, 2004, Pages 988-998

  Grogg, Karen L ^a   Lae, Marick E ^a   Kurtin, Paul J ^a   Macon, William R ^a,b  

^a MAYO CLINIC   (United States)

^b Dept of Lab Medicine and Pathology ^*  (United States)

Author keywords

Clusterin; Follicular dendritic cell tumor; Immunohistochemistry; Interdigitating dendritic cell tumor; Langerhans cell histiocytosis

Indexed keywords

CD23 ANTIGEN; CLUSTERIN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; PROTEIN S 100; T6 ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CELL LINE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENDRITIC CELL; DENDRITIC CELL NEOPLASM; FEMALE; FOLLICULAR DENDRITIC CELL; FOLLICULAR DENDRITIC CELL TUMOR; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERDIGITATING DENDRITIC CELL TUMOR; LANGERHANS CELL; MALE; PROTEIN EXPRESSION; SARCOMA; STAINING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; CLUSTERIN; COMBINED MODALITY THERAPY; DENDRITIC CELLS, FOLLICULAR; FEMALE; GLYCOPROTEINS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MIDDLE AGED; MOLECULAR CHAPERONES; NEOPLASM PROTEINS; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 3242765886     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000112536.76973.7f     Document Type: Article

References (31)

1. Andriko J, Kaldjian E, Tsokos M, et al. Reticulum cell neoplasms of lymph nodes: a clinicopathologic study of 11 cases with recognition of a new subtype derived from fibroblastic reticular cells. Am J Surg Pathol. 1998;22:1048-1058.
2. Biddle D, Ro J, Yoon G, et al. Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod Pathol. 2002;15:50-58.
3. Bozzola J, Russell L. Electron Microscopy: Principles and Techniques for Biologists. Sudbury, MA: Jones and Bartlett; 1992.
4. Cessna M, Zhou H, Sanger W, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol. 2002;15:931-938.
5. Chan J, Fletcher C, Nayler S, et al. Follicular dendritic cell sarcoma: clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer. 1997;79:294-313.
6. Cheuk W, Chan J, Shek T, et al. Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol. 2001;25:721-731.
7. Feltkamp C, van Heerde P, Feltkamp-Vroom T, et al. A malignant tumor arising from interdigitating cells; light microscopical, ultrastructural, immuno- and enzyme-histochemical characteristics. Virchows Arch. 1981; 393:183-192.
8. Gaertner E, Tsokos M, Derringer G, et al. Interdigitating dendritic cell sarcoma: a report of four cases and review of the literature. Am J Clin Pathol. 2001;115:589-597.
9. Jones S, Jomary C. Clusterin. Int J Biochem Cell Biol. 2002;34:427-431.
10. July L, Akbari M, Zellweger I, et al. Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostate. 2002;50:179-188.
11. Kawachi K, Nakatani Y, Inayama Y, et al. Interdigitating dendritic cell sarcoma of the spleen: report of a case with a review of the literature. Am J Surg Pathol. 2002;26:530-537.
12. Kay D. ed. Techniquesfor Electron Microscopy, 2nd ed. Oxford: Blackwell Scientific; 1965.
13. Lae M, Ahmed I, Macon WR. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. Am J Clin Pathol. 2002;118:773-779.
14. Luk I, Shek T, Tang V, et al. Interdigitating dendritic cell tumor of the testis: a novel testicular spindle cell neoplasm. Am J Surg Pathol. 1999; 23:1141-1148.
15. Miettinen M, Fletcher C, Lasota J. True histiocytic lymphoma of small intestine: analysis of two S-100 protein-positive cases with features of interdigitating reticulum cell sarcoma. Am J Clin Pathol. 1993;100:285-292.
16. Nakamura S, Hara K, Suchi T, et al. Interdigitating cell sarcoma: a morphologic, immunohistologic, and enzyme-histochemical study. Cancer. 1988;61:562-568.
17. Nakamura S, Koshikawa T, Kitoh K, et al. Interdigitating cell sarcoma: a morphologic and immunologic study of lymph node lesions in four cases. Pathol Int. 1994;44:374-386.
18. Nascimento A, Pinkus J, Pinkus G. Clusterin, a marker for anaplastic large cell lymphoma: immunohistochemical profile in hematopoietic and non-hematopoietic malignancies. Mod Pathol. 2003;16:246A.
19. Perez-Ordonez B, Erlandson R, Rosai J. Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol. 1996;20:944-955.
20. Perez-Ordonez B, Rosai J. Follicular dendritic cell tumor: review of the entity. Semin Diagn Pathol. 1998;15:144-154.
21. Pileri S, Grogan T, Harris N, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1-29.
22. Pinkus G, Lones M, Matsumura F, et al. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker. Am J Clin Pathol. 2002;118:335-343.
23. Raymond I, Al Saati T, Tkaczuk J, et al. CNA.42, a new monoclonal antibody directed against a fixative-resistant antigen of follicular dendritic reticulum cells. Am J Pathol. 1997;151:1577-1585.
24. Redondo M, Villar E, Torres-Munoz J, et al. Overexpression of clusterin in human breast carcinoma. Am J Pathol. 2000;157:393-399.
25. Rousselet M, Francois S, Croue A, et al. A lymph node interdigitating reticulum cell sarcoma. Arch Pathol Lab Med. 1994;118:183-188.
26. Ruco L, Gearing A, Pigott R, et al. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic cells. Histopathology. 1991;19:523-528.
27. Saffer H, Wahed A, Rassidakis G, et al. Clusterin expression in malignant lymphomas: a survey of 266 cases. Mod Pathol. 2002;15:1221-1226.
28. Weiss L, Berry G, Dorfman R, et al. Spindle cell neoplasms of lymph nodes of probably reticulum cell lineage: true reticulum cell sarcoma? Am J Surg Pathol. 1990;14:405-414.
29. Weiss L, Grogan T, Muller-Hermelink H-K, et al. WHO classification of histiocytic and dendritic cell neoplasms. In: Jaffe E, Harris N, Stein H, et al, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:274-289.
30. Wellman A, Thieblemont C, Pittaluga S, et al. Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large cell lymphomas. Blood. 2000;96:398-404.
31. Xie M, Motoo Y, Su S, et al. Expression of clusterin in human pancreatic cancer. Pancreas. 2002;25:234-238.